SitemapImprintDatenschutzerklärungdeutschenglish
MHH Logo

CAPNETZ

 

 

CAPNETZ - Community Acquired Pneumonia (CAP)

Community acquired pneumonia (CAP) is considered to be one of the most important infectious diseases in the world. The mortality risk of this infection is very high. In Germany approximately 680,000 people suffer from CAP every year. A significant number of these patients have to be treated in hospital.
However, despite this significant health and socio-economic importance reliable data concerning pathogen spectrums and antibiotic resistance patterns as well as the disease courses were largely lacking.

In 2001 the German Ministry of Education and Research (BMBF) identified the need for comprehensive and coordinated research in this field and therefore initiated the excellence network for Community Acquired Pneumonia (CAP).
This network aims at decreasing the disease burden of CAP. In order to achieve this diagnostics, therapy and patient care have to be improved.

CAPNETZ networks medical doctors, microbiologists, virologists, epidemiologists and computer scientists. Leading research facilities in Germany are cooperating within CAPNETZ. All the clinical and biological data are stored in a central material and data bank. In May 2012 nearly 10,000 patients had been included. About one third of these were outpatients, the other two thirds inpatients. Thus, CAPNETZ has the most comprehensive Community Acquired Pneumonia database worldwide.

 

Samples:

  • sera
  • plasma
  • PBMCs
  • throat wash water
  • urine
  • bacterial isolates
  • respiration material
  • EDTA blood

of about  11.000 CAP patients.

 

 

Further information:

www.capnetz.de